FDA Inspection 1257767 — Alim Devani
The FDA completed an inspection of Alim Devani on December 11, 2024 in Calgary. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 11, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Calgary (Canada)
Additional Details
Clinical Investigator (CI)